Concentrations |
9 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations | Note 20 – Concentrations
Major suppliers
The Company sourced approximately 95% and 94% of its inventory purchases from three vendors for the three and nine months ended June 30, 2026, respectively. There was $1.0 million of inventory purchases from major suppliers in accounts payable on the condensed consolidated balance sheets, as of June 30, 2026.
Major customers
Accounts receivable from three customers represented 91% of accounts receivable as of June 30, 2026. Three customers represented 90% of gross sales for the three months ended June 30, 2026.
Credit risk
As of June 30, 2026 and September 30, 2025, the Company’s cash and cash equivalents were deposited in accounts at several financial institutions and may maintain some balances in excess of federally insured limits. The Company maintains its cash and cash equivalents with high-quality, accredited financial institutions and, accordingly, such funds are subject to minimal credit risk. The Company has not experienced any losses historically in these accounts and believes it is not exposed to significant credit risk in its cash and cash equivalents.
The Company is also exposed to credit risk on its trade accounts receivable. In evaluating expected credit losses under ASC 326, the Company considers historical collection experience, the credit quality of its customers, and current economic conditions. Historically, the Company has experienced minimal bad debts and high collection rates, and as such, expected credit losses on accounts receivable are considered low and the related allowance is not material.
|